ClinicalTrials.govpublic full text
Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance
oncogene-addicted non small cell lung cancer, egfr mutation, alk fusion-positive solid or cns tumors, ros1 fusion positive, ret fusion positive, erbb2 mutation-related tumors, ntrk1 fusion positive, ntrk2 fusion positive, ntrk3 fusion positive, nrg1 fusion, braf v600 mutation, kras g12c mutation
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 834144
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.